AllianceBernstein’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Buy |
361,374
+108,860
| +43% | +$551K | ﹤0.01% | 1983 |
|
|
2025
Q1 | $1.34M | Buy |
252,514
+9,300
| +4% | +$49.2K | ﹤0.01% | 2100 |
|
|
2024
Q4 | $1.64M | Buy |
243,214
+25,920
| +12% | +$175K | ﹤0.01% | 2071 |
|
|
2024
Q3 | $1.43M | Hold |
217,294
| – | – | ﹤0.01% | 2141 |
|
|
2024
Q2 | $1.63M | Buy |
217,294
+73,250
| +51% | +$549K | ﹤0.01% | 2068 |
|
|
2024
Q1 | $1.44M | Sell |
144,044
-66,872
| -32% | -$667K | ﹤0.01% | 2086 |
|
|
2023
Q4 | $2.08M | Buy |
210,916
+47,794
| +29% | +$471K | ﹤0.01% | 1915 |
|
|
2023
Q3 | $1.25M | Sell |
163,122
-145,540
| -47% | -$1.11M | ﹤0.01% | 2119 |
|
|
2023
Q2 | $2.31M | Hold |
308,662
| – | – | ﹤0.01% | 1829 |
|
|
2023
Q1 | $2.06M | Sell |
308,662
-81,943
| -21% | -$547K | ﹤0.01% | 1857 |
|
|
2022
Q4 | $3.01M | Sell |
390,605
-2,846,739
| -88% | -$21.9M | ﹤0.01% | 1671 |
|
|
2022
Q3 | $34.4M | Sell |
3,237,344
-363,616
| -10% | -$3.87M | 0.02% | 655 |
|
|
2022
Q2 | $29.3M | Buy |
3,600,960
+220,242
| +7% | +$1.79M | 0.01% | 735 |
|
|
2022
Q1 | $24.2M | Buy |
3,380,718
+504,899
| +18% | +$3.62M | 0.01% | 843 |
|
|
2021
Q4 | $49.3M | Buy |
2,875,819
+1,236,478
| +75% | +$21.2M | 0.02% | 625 |
|
|
2021
Q3 | $37.7M | Buy |
1,639,341
+339,419
| +26% | +$7.81M | 0.01% | 704 |
|
|
2021
Q2 | $47.4M | Buy |
+1,299,922
| New | +$47.4M | 0.02% | 633 |
|